Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127062212 | 12706221 | 2 | F | 20160624 | 20160901 | 20160901 | PER | US-JAZZ-2016-US-007937 | JAZZ | 0.00 | F | Y | 0.00000 | 20160901 | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127062212 | 12706221 | 1 | PS | XYREM | SODIUM OXYBATE | 1 | Oral | 0.75 G, BID | 21196 | .75 | G | ORAL SOLUTION | |||||||
127062212 | 12706221 | 2 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | DOSE ADJUSTMENTS | 21196 | ORAL SOLUTION | |||||||||
127062212 | 12706221 | 3 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 3 G, BID | 21196 | 3 | G | ORAL SOLUTION | |||||||
127062212 | 12706221 | 4 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 4 G, BID | 21196 | 4 | G | ORAL SOLUTION | |||||||
127062212 | 12706221 | 5 | SS | NUVIGIL | ARMODAFINIL | 1 | N | 0 | |||||||||||
127062212 | 12706221 | 6 | C | ANAFRANIL | CLOMIPRAMINE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
127062212 | 12706221 | 7 | C | INDERAL | PROPRANOLOL HYDROCHLORIDE | 1 | U | 0 | |||||||||||
127062212 | 12706221 | 8 | C | PROMETHAZINE | PROMETHAZINEPROMETHAZINE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
127062212 | 12706221 | 9 | C | ATIVAN | LORAZEPAM | 1 | U | 0 | |||||||||||
127062212 | 12706221 | 10 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | U | 0 | |||||||||||
127062212 | 12706221 | 11 | C | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | U | 0 | |||||||||||
127062212 | 12706221 | 12 | C | ADVIL | IBUPROFEN | 1 | U | 0 | |||||||||||
127062212 | 12706221 | 13 | C | IMITREX | SUMATRIPTAN SUCCINATE | 1 | U | 0 | |||||||||||
127062212 | 12706221 | 14 | C | PROPRANOLOL | PROPRANOLOLPROPRANOLOL HYDROCHLORIDE | 1 | U | 0 | |||||||||||
127062212 | 12706221 | 15 | C | PROTONIX | PANTOPRAZOLE SODIUM | 1 | U | 0 | |||||||||||
127062212 | 12706221 | 16 | C | Protriptyline hcl | 2 | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127062212 | 12706221 | 1 | Narcolepsy |
127062212 | 12706221 | 5 | Product used for unknown indication |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127062212 | 12706221 | Anxiety | |
127062212 | 12706221 | Drug ineffective |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127062212 | 12706221 | 1 | 201602 | 201603 | 0 | |
127062212 | 12706221 | 3 | 201604 | 201604 | 0 | |
127062212 | 12706221 | 4 | 201604 | 0 |